Through the implementation of our Lkb1XTR allele, we have uncovered a role for LKB1 at the interface of differentiation enforcement and proliferative control in lung cancer in addition to demonstrating that established lung tumors remain sensitive to its tumor-suppressive activity. The gene discussed is STK11; the disease is neoplasm.